Official matched intervention · Drug

Larazotide Acetate clinical trials

2 selected ClinicalTrials.gov records carrying the official matched intervention Larazotide Acetate (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.

Registry records

2 selected records.

Connected peptides

1 profiles.

Source boundary

ClinicalTrials.gov intervention field.

Cross-source journeys

Explore connected peptide records

Across these connected profiles, PeptideScanner carries 5 selected PubMed records and 0 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.

Collection change ledger

Recently changed records on this intervention hub

All recent changes →

These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.

Record added

ClinicalTrials.gov record NCT01396213

PeptideScanner retained ClinicalTrials.gov record NCT01396213 at 2026-11-16T01:45:58.486Z. Its registry update date was 2017-09-20, and PeptideScanner's reviewed identity mapping was larazotide.

PeptideScanner change date
November 16, 2026
Cited source date
September 20, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05747534

PeptideScanner retained ClinicalTrials.gov record NCT05747534 at 2026-11-16T01:45:58.486Z. Its registry update date was 2026-08-18, and PeptideScanner's reviewed identity mapping was larazotide.

PeptideScanner change date
November 16, 2026
Cited source date
August 18, 2026
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →